INR 66.23
(-0.78%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 558 Million INR | 204.09% |
2022 | 183.5 Million INR | 836.95% |
2021 | -24.9 Million INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 163 Million INR | 0.0% |
2023 FY | - INR | 204.09% |
2023 Q1 | 152.2 Million INR | 0.0% |
2023 Q4 | 92.8 Million INR | -49.29% |
2023 Q2 | 128.5 Million INR | -15.57% |
2023 Q3 | 183 Million INR | 42.41% |
2022 FY | - INR | 836.95% |
2021 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Brookfield India RET | -8.02 Billion INR | 106.957% |
EMBASSY OFFICE PAR | 29.02 Billion INR | 98.078% |
Entero Healthcare Solutions Limited | 1.26 Billion INR | 55.751% |
Gloster Limited | 785.47 Million INR | 28.96% |
GPT Healthcare Limited | 925.19 Million INR | 39.689% |
Indegene Limited | 4.85 Billion INR | 88.502% |
India Shelter Finance Corporation Limited | 6.18 Billion INR | 90.98% |
Jupiter Life Line Hospitals Limited | 2.64 Billion INR | 78.875% |
Medi Assist Health Ser L | 1.3 Billion INR | 57.283% |
Rashi Peripherals Limited | 3.21 Billion INR | 82.64% |
SRG Housing Finance Limited | 329.72 Million INR | -69.232% |
Yatharth Hospital & Trauma Care Services Limited | 1.97 Billion INR | 71.752% |